Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
BIOMARIN PHARMACEUTICAL INC | Director | Common Stock | 21,360 | $1.65 M | $77.05 | May 21, 2024 | Direct |
AGIOS PHARMACEUTICALS, INC. | Director | Common stock | 14,912 | $728 K | $48.84 | Jun 13, 2024 | Direct |
Neumora Therapeutics, Inc. | Director | Common Stock | 20,100 | $241 K | $11.98 | Jun 13, 2024 | Direct |
AGIOS PHARMACEUTICALS, INC. | Director | Restricted stock units | 2,120 | $104 K | $48.84 | Jun 20, 2024 | Direct |
FIBROGEN INC | Director | Common Stock | 31,501 | $23.9 K | $0.76 | Jun 8, 2023 | Direct |
FIBROGEN INC | Director | Stock Option (Right to Buy) | 70,000 | Jun 5, 2024 | Direct | ||
Neumora Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 28,571 | Jun 13, 2024 | Direct | ||
AGIOS PHARMACEUTICALS, INC. | Director | Stock options (right to buy) | 11,774 | Jun 20, 2024 | Direct |